Us OAB Treatment Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
OAB Treatment Market was valued at USD 4.5 Billion in 2022 and is projected to reach USD 7.5 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
Overactive bladder (OAB) affects millions in the United States, leading to a burgeoning market for effective treatments. Recent advancements have introduced innovative therapies, reshaping patient care and expanding market dynamics.
One notable development is the approval of vibegron, marketed as Gemtesa. Approved in December 2020, vibegron offers a novel approach by targeting the β3 adrenergic receptor, aiding bladder relaxation and reducing OAB symptoms. Its introduction has provided an alternative for patients unresponsive to traditional treatments.
Mirabegron, another β3 adrenergic receptor agonist, has been in use since 2012. Common side effects include high blood pressure, headaches, and urinary tract infections. Other significant side effects include urinary retention, irregular heart rate, and angioedema. It works by activating the β3 adrenergic receptor in the bladder, resulting in its relaxation. Mirabegron is the first clinically available beta-3 agonist with approval for use in adults with overactive bladder. Mirabegron was approved for medical use in the United States and in the European Union in 2012. In 2022, it was the 222nd most commonly prescribed medication in the United States, with more than 1 million prescriptions. It is available as a generic medication. In the United Kingdom it is less preferred to antimuscarinic medication such as oxybutynin.
Beyond pharmacological solutions, percutaneous tibial nerve stimulation (PTNS) has emerged as a minimally invasive neuromodulation therapy. PTNS involves electrical stimulation of the tibial nerve, which can alleviate OAB symptoms. This therapy offers an option for patients seeking non-drug interventions.
Market trends indicate a growing preference for these advanced treatments, driven by their efficacy and patient satisfaction. The U.S. OAB treatment market is projected to continue its expansion, with increasing adoption of both pharmacological and non-pharmacological therapies.
In my experience, patients have reported significant improvements with these newer treatments, highlighting the importance of personalized care plans. As the market evolves, staying informed about these options is crucial for both patients and healthcare providers.
Get an In-Depth Research Analysis of the Global OAB Treatment Market Size And Forecast [2025-2032]
AbbVie
Astellas Pharma
Pfizer
Teva
Johnson & Johnson
Kyorin Pharmaceutical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global OAB Treatment Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global OAB Treatment Market
Active Cold Chain
Passive Cold Chain
Hybrid Cold Chain
Refrigerated Trucks
Reefer Containers
Air Freight Solutions
Rail Freight
Pharmaceuticals
Food and Beverage
Biotechnology
Healthcare
Chemicals
Thermal Pallets
Insulated Containers
Active Packaging
Passive Packaging
Transportation Services
Warehousing Services
Monitoring Services
Consulting Services
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ OAB Treatment Market Research Analysis
1. Introduction of the Global OAB Treatment Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global OAB Treatment Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global OAB Treatment Market, By Type
6. Global OAB Treatment Market, By Application
7. Global OAB Treatment Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global OAB Treatment Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/